Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis

Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): Ten-year experience at a single center

(2012) Rodrigo Cartin-Ceba et al.   ARTHRITIS AND RHEUMATISM

Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis

(2012) Rona M. Smith et al.   ARTHRITIS AND RHEUMATISM

Safety of rituximab in rheumatoid arthritis: A long-term prospective single-center study of gammaglobulin concentrations and infections

(2012) Anne Isvy et al.   JOINT BONE SPINE

Complications of long-term therapy for ANCA-associated systemic vasculitis

(2012) Nadezhda Wall et al.   Nature Reviews Nephrology

Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides

(2012) Nils Venhoff et al.   PLoS One

Total serum immunoglobulin levels in patients with RA after multiple B-cell depletion cycles based on rituximab: relationship with B-cell kinetics

(2012) Inmaculada De La Torre et al.   RHEUMATOLOGY

In Vitro Effects of Rituximab on the Proliferation, Activation and Differentiation of Human B Cells

(2011) E. G. Kamburova et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis

(2011) C. ROUBAUD-BAUDRON et al.   JOURNAL OF RHEUMATOLOGY

Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry

(2010) J.-E. Gottenberg et al.   ARTHRITIS AND RHEUMATISM

Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

(2010) E. P. Rhee et al.   Clinical Journal of the American Society of Nephrology

Does rituximab increase the incidence of infectious complications? A narrative review

(2010) Theodoros Kelesidis et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Diagnostic strategy for patients with hypogammaglobulinemia in rheumatology

(2010) Maxime Samson et al.   JOINT BONE SPINE

Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials

(2010) R. F. van VOLLENHOVEN et al.   JOURNAL OF RHEUMATOLOGY

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis

(2009) Rachel B. Jones et al.   ARTHRITIS AND RHEUMATISM

Translational Mini-Review Series on B Cell-Directed Therapies: The pathogenic role of B cells in autoantibody-associated autoimmune diseases - lessons from B cell-depletion therapy

(2009) M. J. Leandro et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

The late adverse events of rituximab therapy – rare but there!

(2009) Ron Ram et al.   LEUKEMIA & LYMPHOMA

B-Cell–Depleting Induction Therapy and Acute Cellular Rejection

(2009) Menna R. Clatworthy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab off-label use for immune diseases: assessing adverse events in a single-centre drug-utilization survey

(2008) Laurent Sailler et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY